Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Student Transformation Forum kicks off
2010-08-19

Ms Nida Jooste and Ms Modieyi Mothole
Photo: Lize du Plessis

The establishment of a Broad Student Transformation Forum (BSTF) at the University of the Free State (UFS) was initiated yesterday with a student consultative forum called to determine the agenda and delegations to the BSTF.

The establishment of the BSTF follows the suspension of the functioning of the Student Representative Council (SRC) recently and aims to provide students broadly with the opportunity to reach consensus regarding student governance at the Main Campus in Bloemfontein.

The meeting was chaired by student affairs specialist Prof. Cecil Bodibe and was attended by representatives from student associations from all faculties, representatives of non-faculty student associations and representatives from residences. Commuter students were represented through private student associations.

“The meeting clearly expressed agreement that decisions taken by the BSTF should ensure that the student body and student-life programmes truly reflect our constitutional commitment to building a non-racial, non-sexist and democratic society, and that collaboration between students and management in affecting the decisions of the BSTF to achieve this should be prioritised,” Mr Rudi Buys, Dean of Student Affairs, said.

The forum agreed that apart from addressing specific questions pertaining to student governance, the BSTF should also address transformation issues broadly. The forum also agreed that the delegations to the BSTF should ensure that the forum is truly representative of the diverse student population and is inclusive of all stakeholder groups, including international students and students with disability. A proper process to determine the credentials of participating association was requested and will be implemented.

The meeting furthermore expressed the wish that the BSTF should exist only to determine the key changes that should be made to student governance now, so that the postponed SRC elections may continue as soon as possible. The BSTF will thus have a temporary role to enable the student body to reach consensus regarding changes to the SRC constitution.

Meanwhile, an Interim Student Committee (ISC) was appointed, which has the role to ensure the continuation of daily student life programmes and to ensure student representation in management and governance of the university continues during the deliberations of the BSTF. The ISC serves as an interim structure that will dissolve when a new SRC takes office following the outcome of the BSTF and the continuation of the SRC election.

The ISC consists of 15 members who were appointed through a process of nomination of four (4) members each from the faculty-student associations, non-faculty student associations and from residences, and three (3) members from the student executive committees of Kovsie Community Service, the Irawa student newspaper and the Kovsie Rag executive committee.

The ISC elected Ms Modieyi Mothole and Ms Nida Jooste as its chairperson and deputy-chairperson, respectively.
“I’m encouraged with the initiative and response of students to ensure student governance continues, which bears witness to the depth of leadership our student body holds, while the level of engagement by students in the BSTF indicates that the student body seriously consider issues of transformation,” said Mr Buys.

Media Release
Issued by: Lacea Loader
Director: Strategic Communication (actg.)
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl@ufs.ac.za  
19 August 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept